The general purposes of this invention are 1) to provide bulk quantities of relatively pure soluble antigens of the human major histocompatibility complex; and 2) to determine whether or not soluble forms of the normally surface-bound HLA antigens could be used for diagnostic
Murine Monoclonal Anitbodies Against Normal Malignant Human T-Cells. (Leu-9)
Lab designation: SBCV9.1, This hybridoma produces a monoclonal antibody IgG2b against normal and malignant human T cells. It appears to be an equivalent of anti-Leu-9.